文献速递泌尿生殖介入MRCT

基于多参数前列腺MRI的前列腺钙化引导调强放疗

Multiparametric prostate MRI-based intensity-modulated radiation therapy guided by prostatic calcifications.
PubMed 文献 · Br J Radiol · 2020-08-26

研究纳入94例连续患者,2015年1月至2017年12月接受基于锥形束CT(CBCT)的前列腺钙化引导图像引导放疗(IGRT),计划基于多参数前列腺MRI,无需基准标记。中位随访39.7个月,68%患者可见前列腺内结石,3年生化控制率96%,晚期≥2级直肠毒性3%、泌尿毒性7%,钙化存在未显著影响生化控制与毒性。

要点

  • 前列腺钙化可作天然基准标记用于无创IGRT,3年生化控制率96%。
  • 68%患者可见前列腺内结石,其存在与否未显著影响生化控制和毒性。
  • 晚期≥2级直肠毒性和泌尿毒性分别为3%和7%。

核心结论

  • 前列腺钙化可作为天然基准标记,实现无创IGRT,早期疾病控制和毒性结果有前景。
  • 前列腺钙化引导的IGRT在技术上是可行的。

研究设计与样本

  • 单臂研究,2015年1月至2017年12月连续纳入94例接受CBCT引导IGRT的前列腺癌患者。
  • IGRT基于多参数前列腺MRI计划,不使用基准标记,常规整合MRI用于靶区勾画并对前列腺内肿瘤结节进行推量。
  • 主要终点为前列腺钙化患病率,毒性和生化控制为次要终点。

诊断标准与关键数值

  • 68%的患者可见前列腺内结石。
  • 3年生化控制率为96%,晚期≥2级直肠毒性为3%,晚期≥2级泌尿毒性为7%。
  • 前列腺钙化存在与否对生化控制和毒性无显著影响。

临床应用与阅片要点

  • 前列腺钙化可替代基准标记用于CBCT引导IGRT的定位。
  • 基于多参数MRI的计划可对前列腺内肿瘤结节推量,同时降低正常前列腺剂量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The optimal technique to administer image-guided radiation therapy for prostate cancer remains poorly defined. This study assessed outcomes after multiparametric prostate MRI-based planning was delivered with image-guided radiation therapy using prostatic calculi observed on cone beam CT (CBCT).

METHODS: Between January 2015 and December 2017, 94 consecutive patients were treated with CBCT-based image-guided radiation therapy (IGRT) without fiducial markers. MRI was routinely incorporated for target delineation and intraprostatic tumor nodules were boosted to allow reduced doses to normal appearing prostate. The primary endpoint was the prevalence of prostatic calcifications while toxicity and biochemical control were secondary endpoints.

RESULTS: Median follow-up was 39.7 months with 82% NCCN intermediate to very high risk. Intraprostatic calculi were noted in 68% of patients. The 3-year biochemical control, late grade ≥2 rectal toxicity and late grade ≥2 urinary toxicity rates were 96%, 3 and 7%, respectively. Biochemical control and toxicity were not significantly impacted by the presence of prostatic calculi.

CONCLUSION: Prostatic calcifications can serve as natural fiducial markers to allow for non-invasive IGRT for prostate cancer with promising early disease control and toxicity outcomes.

ADVANCES IN KNOWLEDGE: Prostate calcification-guided IGRT is technically feasible.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Kao J, Karwowski P, Pettit J, et al. Multiparametric prostate MRI-based intensity-modulated radiation therapy guided by prostatic calcifications. Br J Radiol. 2020. PMID: 32846099. doi:10.1259/bjr.20200571

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。